0001809245-22-000003.txt : 20220404 0001809245-22-000003.hdr.sgml : 20220404 20220404170124 ACCESSION NUMBER: 0001809245-22-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220404 DATE AS OF CHANGE: 20220404 EFFECTIVENESS DATE: 20220404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pyros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001809245 IRS NUMBER: 821881210 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-440299 FILM NUMBER: 22803426 BUSINESS ADDRESS: STREET 1: 2001 ROUTE 46, SUITE 310 CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 201-743-9468 MAIL ADDRESS: STREET 1: 2001 ROUTE 46, SUITE 310 CITY: PARSIPPANY STATE: NJ ZIP: 07054 D 1 primary_doc.xml X0708 D LIVE 0001809245 Pyros Pharmaceuticals, Inc. 2001 Route 46, Suite 310 Parsippany NJ NEW JERSEY 07054 201-743-9468 DELAWARE None None Corporation true 2019 Michael Smith c/o Pyros Pharmaceuticals, Inc. 2001 Route 46, Suite 310 Parsippany NJ NEW JERSEY 07054 Executive Officer Director Edwin Urrutia c/o Pyros Pharmaceuticals, Inc. 2001 Route 46, Suite 310 Parsippany NJ NEW JERSEY 07054 Executive Officer Director Ron Tilles c/o Pyros Pharmaceuticals, Inc. 2001 Route 46, Suite 310 Parsippany NJ NEW JERSEY 07054 Director Other Decline to Disclose 06b false 2022-03-21 false true false 1 5000000 450000 4550000 false 1 0 0 0 false Pyros Pharmaceuticals, Inc. /s/Michael Smith Michael Smith Chief Executive Officer 2022-04-04